SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Total revenue for the quarter ended December 2024 of  Rs. 11.68 millions grew by 258.28% from Rs. 3.26 millions.The Total Profit for the quarter ended December 2024 of Rs. 84.33 millions grew from Rs.-6.51 millions Operating profit Margin for the quarter ended December 2024 improved to 30.84% as compared to -3.01% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 11.68 3.26 258.28 23.10 28.26 -18.26 38.11 37.07 2.81
Other Income 56.61 13.27 326.60 139.03 44.73 210.82 78.93 105.34 -25.07
PBIDT 30.84 -3.01 -1124.58 82.76 -16.36 -605.87 11.21 53.76 -79.15
Interest 1.01 0.56 80.36 2.88 1.25 130.40 1.92 1.07 79.44
PBDT 81.36 -3.57 -2378.99 131.41 -17.61 -846.22 9.29 44.81 -79.27
Depreciation 0.20 0.28 -28.57 0.79 0.86 -8.14 1.16 1.45 -20.00
PBT 81.16 -3.85 -2208.05 130.62 -18.47 -807.20 8.13 43.36 -81.25
TAX -3.17 2.66 -219.17 -1.45 2.66 -154.51 -17.69 2.26 -882.74
Deferred Tax -1.05 2.66 -139.47 -1.45 2.66 -154.51 3.86 2.26 70.80
PAT 84.33 -6.51 -1395.39 132.07 -21.13 -725.04 25.82 41.10 -37.18
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 264.04 -92.33 -385.97 358.27 -57.89 -718.87 29.41 145.02 -79.72

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×